Skip to main content
Fig. 4 | Human Genomics

Fig. 4

From: Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics

Fig. 4

a Odds ratio values of pharmacogenomics (PGx) variants of common (MAF > 0.10) or intermediate (0.05 ≤ MAF ≤ 0.10) frequency are plotted alongside with the 95% of their confidence intervals. The PGx variants are colored based on the antipsychotic or antidepressant drug of the association. b Odds ratio values of pharmacogenomics (PGx) variants of low frequency (0.01 ≤ MAF < 0.05); rare (MAF < 0.01) frequency are plotted alongside with the 95% of their confidence intervals. Moreover, the odds ratio values and the confidence intervals of pharmacogenomics variants that were not found within the 1000 Genomes project are also plotted. The PGx variants are colored based on the antipsychotic or antidepressant drug association

Back to article page